Deciphera Pharmaceuticals, Inc. Operating Lease Right-of-Use Assets
Deciphera Pharmaceuticals, Inc. had Operating Lease Right-of-Use Assets of $30.93 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-05-10
- 2024-03-31: Operating Lease, Right-of-Use Asset $30.93M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $32.07M.
- 2023-09-30: Operating Lease, Right-of-Use Asset $33.21M.
- 2023-06-30: Operating Lease, Right-of-Use Asset $34.33M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2024-03-31 | $30.93M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $32.07M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $33.21M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $34.33M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $35.45M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $36.55M 10-K · filed 2024-02-07 |
| 2022-09-30 | $37.64M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $38.68M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $35.85M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $36.80M 10-K · filed 2023-02-07 |
| 2021-09-30 | $34.28M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $35.13M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $35.88M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $36.34M 10-K · filed 2022-02-08 |
| 2020-09-30 | $37.17M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $20.10M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $20.63M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $21.16M 10-K · filed 2021-02-09 |
| 2019-09-30 | $522.00K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $476.00K 10-Q · filed 2019-08-02 |
| 2019-03-31 | $670.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-09 |